Therapeutic neutralization of CXCL10 decreases secondary degeneration and functional deficit after spinal cord injury in mice.

Abstract:

:Inflammation plays a critical role in the secondary degenerative response to spinal cord injury (SCI). The influx of inflammatory cells following SCI is preceded by the expression of specific chemoattractants, including chemokines. The chemokine CXCL10 is a potent T lymphocyte recruiter and has been strongly implicated in the pathology of many CNS disorders. We have previously demonstrated that CXCL10 exacerbates secondary degeneration by blocking the function of CXCL10 prior to SCI. Here we administered neutralizing antibodies against CXCL10 1 h after SCI in order to investigate the efficacy of this therapeutic intervention in abating histologic and functional deficit following acute SCI and further assess the functional role of CXCL10 in secondary degeneration. Neutralization of CXCL10 significantly reduced inflammation, apoptosis, neuronal loss and whole tissue loss. Notably, this therapeutic treatment also promoted revascularization of the injured spinal cord and functional recovery. These data suggest that anti-CXCL10 antibody treatment is a viable therapeutic strategy for acute SCI.

journal_name

Regen Med

journal_title

Regenerative medicine

authors

Gonzalez R,Hickey MJ,Espinosa JM,Nistor G,Lane TE,Keirstead HS

doi

10.2217/17460751.2.5.771

subject

Has Abstract

pub_date

2007-09-01 00:00:00

pages

771-83

issue

5

eissn

1746-0751

issn

1746-076X

journal_volume

2

pub_type

杂志文章
  • Autologous cell therapies: the importance of regulatory oversight.

    abstract::Promising new medical technologies and approaches to treatment offer the potential to substantially improve the lives of patients who need help, and in some cases transform the way medicine is practiced. In recent years, the biotechnology industry has generated many examples of new approaches that are having a profoun...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme.12.90

    authors: Werner M,Mayleben T,Van Bokkelen G

    更新日期:2012-11-01 00:00:00

  • Using poly(lactide-co-glycolide) electrospun scaffolds to deliver cultured epithelial cells to the cornea.

    abstract:AIMS:To assess the potential of electrospun poly(lactide-co-glycolide) membranes to provide a biodegradable cell carrier system for limbal epithelial cells. MATERIAL & METHODS:50:50 poly(lactide-co-glycolide) scaffolds were spun, sterilized and seeded with primary rabbit limbal epithelial cells. Cells were cultured on...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme.10.16

    authors: Deshpande P,McKean R,Blackwood KA,Senior RA,Ogunbanjo A,Ryan AJ,MacNeil S

    更新日期:2010-05-01 00:00:00

  • Isolation of fibroblasts for coating of meshes for reconstructive surgery: differences between mesh types.

    abstract:AIMS:An extensive colonization of surgical meshes with autologous fibroblasts may reduce complications. Therefore, we aimed to establish a technique that allows isolation and propagation of fibroblasts from vaginal biopsies. Using these cells we tested the applicability of several clinically applied meshes for fibrobla...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/17460751.4.2.197

    authors: Skala CE,Petry IB,Gebhard S,Hengstler JG,Albrich SB,Maltaris T,Naumann G,Koelbl H

    更新日期:2009-03-01 00:00:00

  • Fibrin hydrogels to deliver dental stem cells of the apical papilla for regenerative medicine.

    abstract:AIM:Evaluation of survival, proliferation and neurodifferentiation of dental stem cells from the apical papilla (SCAP) in fibrin hydrogels. We hypothesized that fibrin composition will influence cell behavior. METHODS:Modulus, pore and fiber size were measured. SCAP in vitro viability, proliferation and neural differe...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme.14.81

    authors: Germain L,De Berdt P,Vanacker J,Leprince J,Diogenes A,Jacobs D,Vandermeulen G,Bouzin C,Préat V,Dupont-Gillain C,des Rieux A

    更新日期:2015-01-01 00:00:00

  • Biomaterials combined with cell therapy for treatment of spinal cord injury.

    abstract::Spinal cord injury (SCI) is a devastating traumatic injury resulting in paralysis or sensory deficits due to tissue damage and the poor ability of axons to regenerate across the lesion. Despite extensive research, there is still no effective treatment that would restore lost function after SCI. A possible therapeutic ...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,评审

    doi:10.2217/rme.11.121

    authors: Kubinová S,Syková E

    更新日期:2012-03-01 00:00:00

  • Developing assays to address identity, potency, purity and safety: cell characterization in cell therapy process development.

    abstract::A major challenge to commercializing cell-based therapies is developing scalable manufacturing processes while maintaining the critical quality parameters (identity, potency, purity, safety) of the final live cell product. Process development activities such as extended passaging and serum reduction/elimination can fa...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,评审

    doi:10.2217/rme.11.105

    authors: Carmen J,Burger SR,McCaman M,Rowley JA

    更新日期:2012-01-01 00:00:00

  • Cardiac repair and restoration using human embryonic stem cells.

    abstract::Advances in directed differentiation of human embryonic stem cells (hESCs) toward cardiac lineages have generated much interest within the myocardial therapy field. Beyond the promise that hESCs would provide a supply of new cardiomyocytes to the damaged heart, recent studies have also shown that paracrine effects of ...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,评审

    doi:10.2217/rme.12.46

    authors: Bernstein HS

    更新日期:2012-09-01 00:00:00

  • Determinants of clinician adoption of regenerative therapies in the UK and Canada: an ophthalmology perspective.

    abstract::The determinants of adoption of regenerative medicine therapies are currently poorly understood. This study aims to draw comparison between the UK and Canada in terms of factors likely to affect healthcare adoption of future regenerative therapies in ophthalmology. Conducting semi-structured interviews with senior oph...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme.14.82

    authors: Rose JB,May M,Williams DJ

    更新日期:2015-05-01 00:00:00

  • Optimizing the safety of intradiscal platelet-rich plasma: an in vitro study with Cutibacterium acnes.

    abstract::Aim: The most common risk associated with intradiscal injection of platelet-rich plasma (PRP) is discitis with Cutibacterium acnes. It is hypothesized that antimicrobial activity of PRP can be enhanced through inclusion of leukocytes or antibiotics in the injectate. Materials & methods: Multiple PRP preparations of va...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2019-0098

    authors: Prysak MH,Lutz CG,Zukofsky TA,Katz JM,Everts PA,Lutz GE

    更新日期:2019-10-01 00:00:00

  • Human mesenchymal stromal cell lysates as a novel strategy to recover liver function.

    abstract:AIM:It is unknown if the beneficial effects of mesenchymal stromal cells (MSC) transplantation into the liver are dependent on their anchorage and differentiation into hepatocytes or rather the result of the release of stem cell intracellular content with hepatoprotector properties. MATERIALS & METHODS:The effects of ...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme.14.59

    authors: Herencia C,Almadén Y,Martínez-Moreno JM,Espejo I,Herrera C,Pérez-Sánchez C,Guerrero F,Ciria R,Briceño FJ,Ferrín G,de la Mata M,Muñoz-Castañeda JR

    更新日期:2015-01-01 00:00:00

  • Musculoskeletal tissue engineering with human umbilical cord mesenchymal stromal cells.

    abstract::Multipotent mesenchymal stromal cells (MSCs) hold tremendous promise for tissue engineering and regenerative medicine, yet with so many sources of MSCs, what are the primary criteria for selecting leading candidates? Ideally, the cells will be multipotent, inexpensive, lack donor site morbidity, donor materials should...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,评审

    doi:10.2217/rme.10.98

    authors: Wang L,Ott L,Seshareddy K,Weiss ML,Detamore MS

    更新日期:2011-01-01 00:00:00

  • Leukocyte-rich platelet-rich plasma application in post-traumatic osteoarthritis with popliteal cyst: a case report.

    abstract::Aim: To describe the successful treatment of a Baker's cyst in the setting of post-traumatic osteoarthritis using ultrasound-guided injection of platelet-rich plasma. Setting: Outpatient sports clinic. Patient: 29-year old male basketball player. Case description: The patient presented with 2-months history of right k...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2020-0021

    authors: Song B,Yeh PC,Jayaram P

    更新日期:2020-06-01 00:00:00

  • New glossary of terms used in regenerative medicine: standardization continues to emerge as regenerative medicine matures.

    abstract::Regenerative medicine is an evolving, cross-disciplinary, international field that, as a result, uses terms that are either not widely understood, or may have a number of different meanings. Many stakeholders have identified this lack of clarity as a potential barrier to effective communication within the field. To ad...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme.09.34

    authors: Sheridan B,Harris N

    更新日期:2009-07-01 00:00:00

  • The regenerative therapies of the ankle degeneration: a focus on multipotential mesenchymal stromal cells.

    abstract::The ankle degeneration ranging from focal osteochondral lesions to osteoarthritis can cause a total joint function loss. With rising life expectancy and activity of the patients, various regenerative therapies were introduced aiming to preserve the joint function via the induction of cartilage and bone repair. Here, b...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2017-0104

    authors: El-Jawhari JJ,Brockett CL,Ktistakis I,Jones E,Giannoudis PV

    更新日期:2018-03-19 00:00:00

  • Periadventitial adipose-derived stem cell treatment halts elastase-induced abdominal aortic aneurysm progression.

    abstract:AIM:Demonstrate that periadventitial delivery of adipose-derived mesenchymal stem cells (ADMSCs) slows aneurysm progression in an established murine elastase-perfusion model of abdominal aortic aneurysm (AAA). MATERIALS & METHODS:AAAs were induced in C57BL/6 mice using porcine elastase. During elastase perfusion, a de...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme.14.61

    authors: Blose KJ,Ennis TL,Arif B,Weinbaum JS,Curci JA,Vorp DA

    更新日期:2014-01-01 00:00:00

  • Diabetes mellitus: an opportunity for therapy with stem cells?

    abstract::In both Type 1 and 2 diabetes, insufficient numbers of insulin-producing beta-cells are a major cause of defective control of blood glucose and its complications. Restoration of damaged beta-cells by endocrine pancreas regeneration would be an ideal therapeutic option. The possibility of generating insulin-secreting c...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,评审

    doi:10.2217/17460751.3.3.377

    authors: Sordi V,Bertuzzi F,Piemonti L

    更新日期:2008-05-01 00:00:00

  • In vitro potential of human mesenchymal stem cells for corneal epithelial regeneration.

    abstract::Aim: To determine the potential of mesenchymal stem cells (MSC) for corneal epithelial regeneration in vitro. Materials & methods: Bone marrow MSC (BM-MSC) and adipose tissue MSC were analyzed for corneal epithelial and mesenchymal markers, using limbal stem cells and corneal cells as controls. MSC with better potenti...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2019-0067

    authors: Nieto-Nicolau N,Martín-Antonio B,Müller-Sánchez C,Casaroli-Marano RP

    更新日期:2020-03-01 00:00:00

  • Research progress and prospects of tissue engineering scaffolds for spinal cord injury repair and protection.

    abstract::Spinal cord injury (SCI) is one of the leading causes of global disability. However, there are currently no effective clinical treatments for SCI. Repair of SCI is essential but poses great challenges. As a comprehensive treatment program combining biological scaffolds, seed cells and drugs or biological factors, tiss...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2018-0156

    authors: Ma Z,Lu Y,Yang Y,Wang J,Kang X

    更新日期:2019-09-01 00:00:00

  • Quality control guidelines for clinical-grade human induced pluripotent stem cell lines.

    abstract::Use of clinical-grade human induced pluripotent stem cell (iPSC) lines as a starting material for the generation of cellular therapeutics requires demonstration of comparability of lines derived from different individuals and in different facilities. This requires agreement on the critical quality attributes of such l...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2018-0095

    authors: Sullivan S,Stacey GN,Akazawa C,Aoyama N,Baptista R,Bedford P,Bennaceur Griscelli A,Chandra A,Elwood N,Girard M,Kawamata S,Hanatani T,Latsis T,Lin S,Ludwig TE,Malygina T,Mack A,Mountford JC,Noggle S,Pereira LV,Pric

    更新日期:2018-10-01 00:00:00

  • Mesenchymal stem cells for vascular regeneration.

    abstract::Mesenchymal stem cells (MSCs) have tremendous potential for regenerative medicine, and have been researched for the treatment of cardiovascular diseases. MSCs are a promising cell type because of their ease of isolation and expansion, their multipotency and their low immunogenicity. However, in order to fully utilize ...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,评审

    doi:10.2217/17460751.3.6.877

    authors: Huang NF,Li S

    更新日期:2008-11-01 00:00:00

  • A panel of tests to standardize the characterization of human embryonic stem cells.

    abstract::Human embryonic stem cells offer a renewable source of a wide range of cell types for use in research and cell-based therapies. Characterizing these cells provides important information about their current state and affords relevant details for subsequent downstream manipulation. Prior to considering therapeutic appli...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/17460751.2.2.179

    authors: Pal R,Mandal A,Rao HS,Rao MS,Khanna A

    更新日期:2007-03-01 00:00:00

  • Chronic ischial tuberosity avulsion nonunion fracture treated with a platelet-rich plasma injection as a bone graft.

    abstract::We present a case of an 18-year-old with a 2-year history of buttock pain who failed extensive treatment for a perceived hamstring strain. Upon evaluation, he was diagnosed with an ischial tuberosity nonunion avulsion fracture. The patient underwent bone grafting via an ultrasound guided leukocyte rich platelet-rich p...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2018-0071

    authors: Stafford CD 2nd,Colberg RE,Nourse AL

    更新日期:2019-05-01 00:00:00

  • Development of cell therapy strategies to overcome copper toxicity in the LEC rat model of Wilson disease.

    abstract:AIMS:Therapeutic replacement of organs with healthy cells requires disease-specific strategies. As copper toxicosis due to ATP7B deficiency in Wilson disease produces significant liver injury, disease-specific study of transplanted cell proliferation will offer insights into cell and gene therapy mechanisms. MATERIALS...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/17460751.3.2.165

    authors: Malhi H,Joseph B,Schilsky ML,Gupta S

    更新日期:2008-03-01 00:00:00

  • Biochemical characterization of pure dehydrated binate amniotic membrane: role of cytokines in the spotlight.

    abstract:AIM:Placental allografts used for tissue regeneration differ in membrane compositions and processing techniques. A uniquely folded dehydrated binate amniotic membrane (DBAM) was biochemically characterized to evaluate its potential role in wound healing. METHODS:Histology, Luminex-based immunoassay and standard in vit...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2018-0085

    authors: Sane MS,Misra N,Quintanar NM,Jones CD,Mustafi SB

    更新日期:2018-09-01 00:00:00

  • Muscle-derived stem cells in peripheral nerve regeneration: reality or illusion?

    abstract::Owing to the complicated and time-consuming regenerative process, the repair of injured peripheral nerves depends largely on ongoing stem-cell therapy. Decades ago, researchers successfully isolated and identified muscle-derived stem cells (MDSCs) and discovered their potential for multidifferentiation. MDSCs play an ...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,评审

    doi:10.2217/rme-2016-0165

    authors: Zhou J,Cui H,Lu H,Xu Z,Feng W,Chen L,Jin X,Yang X,Qi Z

    更新日期:2017-04-01 00:00:00

  • Early evaluation and value-based pricing of regenerative medicine technologies.

    abstract::Since the first pioneering scientists explored the potential of using human cells for therapeutic purposes the branch of regenerative medicine has evolved to become a mature industry. The focus has switched from 'what can be done' to 'what can be commercialized'. Timely health economic evaluation supports successful m...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme.13.69

    authors: Koerber F,Rolauffs B,Rogowski W

    更新日期:2013-11-01 00:00:00

  • Recreating composition, structure, functionalities of tissues at nanoscale for regenerative medicine.

    abstract::Nanotechnology offers significant potential in regenerative medicine, specifically with the ability to mimic tissue architecture at the nanoscale. In this perspective, we highlight key achievements in the nanotechnology field for successfully mimicking the composition and structure of different tissues, and the develo...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,评审

    doi:10.2217/rme-2016-0120

    authors: Alarçin E,Guan X,Kashaf SS,Elbaradie K,Yang H,Jang HL,Khademhosseini A

    更新日期:2016-12-01 00:00:00

  • Sherley v. Sebelius.

    abstract::Following the reversal by the court of appeals of the injunction against federal funding of human embryonic stem cell research, Judge Lamberth has held such funding to be lawful and has dismissed the lawsuit. However, the litigation is likely to continue in the court of appeals and ultimately perhaps in the Supreme Co...

    journal_title:Regenerative medicine

    pub_type: 历史文章,杂志文章

    doi:10.2217/rme.11.70

    authors: Goldfarb N

    更新日期:2011-11-01 00:00:00

  • Current and emerging global themes in the bioethics of regenerative medicine: the tangled web of stem cell translation.

    abstract::Probably the most serious problem facing the field of regenerative medicine today is the challenge of effective translation and development of viable stem cell-based therapies. Particular concerns have been raised over the growing market in unproven cell therapies. In this article, I explore recent developments in the...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2017-0065

    authors: Chan S

    更新日期:2017-10-01 00:00:00

  • Clinical use of autologous micro-fragmented fat progressively restores pain and function in shoulder osteoarthritis.

    abstract::Aim: We aim to show that the use of nondigested micro-fragmented adipose tissue (MFat™, Lipogems®) is a viable alternative for treatment of joint pain and inflammation associated dysfunction in shoulder osteoarthritis (OA). Materials & methods: A total of 25 subjects with OA received an injection of MFat™ and were fol...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2020-0069

    authors: Vinet-Jones H,F Darr K

    更新日期:2020-10-01 00:00:00